Epicardial fat and carotid and femoral intima-mediathicknesses were measured and compared between these groups.Results: Carotid intima-media and epicardial fat thicknesses were significantlyhigher in the patient group than in the control group (0.91±0.08 vs. 0.71±0.1mm, p
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Introduction: Although atherosclerotic cardiovascular diseases and cardiovascularrisks are known to increase in patients with end-stage renal disease, it is notclear whether these risks increase in the geriatric patient population as well.
📊
Temel Bulgular & Veri:Thisstudy aims to evaluate these risks in geriatric patients with end-stage renal diseaseby evaluating epicardial fat and carotid and femoral intima-media thicknesses,known as markers, for subclinical atherosclerosis and cardiovascular risks.Materials and Methods: This cross-sectional study included 52 patients whostarted to receive chronic hemodialysis treatment after the age of 65 years (meanage 73.92±5.63) years with end-stage renal failure and 51 healthy volunteers(mean age: 74.49±4.63 years).
💡
Sonuç & Katkı:Epicardial fat and carotid and femoral intima-mediathicknesses were measured and compared between these groups.Results: Carotid intima-media and epicardial fat thicknesses were significantlyhigher in the patient group than in the control group (0.91±0.08 vs. 0.71±0.1mm, p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Introduction: Although atherosclerotic cardiovascular diseases and cardiovascularrisks are known to increase in patients with end-stage renal disease, it is notclear whether these risks increase in the geriatric patient population as well. Thisstudy aims to evaluate these risks in geriatric patients with end-stage renal diseaseby evaluating epicardial fat and carotid and femoral intima-media thicknesses,known as markers, for subclinical atherosclerosis and cardiovascular risks.Materials and Methods: This cross-sectional study included 52 patients whostarted to receive chronic hemodialysis treatment after the age of 65 years (meanage 73.92±5.63) years with end-stage renal failure and 51 healthy volunteers(mean age: 74.49±4.63 years). Epicardial fat and carotid and femoral intima-mediathicknesses were measured and compared between these groups.Results: Carotid intima-media and epicardial fat thicknesses were significantlyhigher in the patient group than in the control group (0.91±0.08 vs. 0.71±0.1mm, p
🔖
Bu Makaleye Atıf Yap
YILMAZ, M., GÜNEŞLİ, A., YALÇIN, Ç., TEKKARIŞMAZ, N., ALKAN, Ö. (2022). EVALUATION OF EPICARDIAL FAT AND CAROTID AND FEMORAL INTIMA-MEDIA THICKNESSES IN GERIATRIC PATIENTS WITH END-STAGE RENAL DISEASE. Türk Geriatri Dergisi, Cilt: 23 - Sayı: 1, 42–50. https://ajindex.com/articles/623569
Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 2019;73(3S1):A7-A8. (PMID:30798791)
Murphy D, McCulloch CE, Lin F, et al. Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Trends in Prevalence of Chronic Kidney Disease in the United States. Ann Intern Med 2016;165(7):473-81. (PMID:27479614)
Kesikburun B, Ekşioğlu E, Akdağ İ, Çakıcı A. Determination of health-related quality of life in elderly hemodialysis patients. Turkish Journal of Geriatrics 2017;20(3):204-12
Di Lullo L, House A, Gorini A, Santoboni A, Russo D, Ronco C. Chronic kidney disease and cardiovascular complications. Heart Fail Rev 2015;20(3):259-72. (PMID:25344016)
Ansaldo AM, Montecucco F, Sahebkar A, Dallegri F, Carbone F. Epicardial adipose tissue and cardiovascular diseases. Int J Cardiol 2019;278:254- 60. (PMID:30297191)
Carpenter M, Sinclair H, Kunadian V. Carotid Intima Media Thickness and Its Utility as a Predictor of Cardiovascular Disease: A Review of Evidence. Cardiol Rev 2016;24(2):70-5. (PMID:26825762)
Altin C, Sade LE, Gezmis E, Yilmaz M, Ozen N, Muderrisoglu H. Assessment of epicardial adipose tissue and carotid/femoral intima media thickness in insulin resistance. J Cardiol 2017;69(6):843-50. (PMID:27613385)
Qaseem A, Hopkins RH Jr, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2013;159(12):835-47. (PMID:24145991)
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28(1):1–39. (PMID:25559473)
Sengul C, Ozveren O. Epicardial adipose tissue: a review of physiology, pathophysiology, and clinical applications. Anadolu Kardiyol Derg 2013;13(3):261- 5. (PMID:23395709)
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013;382(9889):339-52. (PMID:23727170)
Wang J, Wang F, Liu S, Zhou M, Zhang L, Zhao M. Reduced Kidney Function, Albuminuria, and Risks for All- cause and Cardiovascu